FKBP12 PROTAC RC32 is primarily used in biomedical research to study targeted protein degradation. It functions as a proteolysis-targeting chimera (PROTAC), a novel approach to selectively degrade specific proteins within cells. This chemical is particularly valuable in understanding the role of FKBP12, a protein involved in various cellular processes, including protein folding and signal transduction. Researchers utilize FKBP12 PROTAC RC32 to investigate disease mechanisms, especially in conditions where FKBP12 dysregulation is implicated, such as cancer or neurodegenerative disorders. Its application also extends to drug discovery, where it serves as a tool to validate potential therapeutic targets by demonstrating the effects of protein degradation on cellular function and disease progression.